Evidence map›Paper›PMID 32483324›Full record

ReviewNature reviews. Microbiology2020

Ecology and genomics of Actinobacteria: new concepts for natural product discovery.

Doris A van Bergeijk, Barbara R Terlouw, Marnix H Medema, Gilles P van Wezel

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 206 papers.

0numbers the graph read from it
0cells of the map it votes in
206citing papers in PubMed
33.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

206 citing papers in PubMed, 430 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biosynthetic diversity and antifungal potential of soil-derivedApplied and environmental microbiology · 2026
    Article
  5. Article
  6. The Underexplored GenusMarine drugs · 2026
    Review
  7. Article
  8. Article
  9. International journal of systematic and evolutionary microbiology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. ExploringMicrobiology (Reading, England) · 2026
    Review
  18. Review
  19. Article
  20. Article

146 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Doris A van Bergeijk *Microbial Biotechnology, Institute of Biology, Leiden University, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-2316-920X
Barbara R Terlouw *Bioinformatics Group, Wageningen University, Wageningen, The Netherlands.
Marnix H MedemaBioinformatics Group, Wageningen University, Wageningen, The Netherlands. marnix.medema@wur.nl.ORCID http://orcid.org/0000-0002-2191-2821
Gilles P van WezelMicrobial Biotechnology, Institute of Biology, Leiden University, Leiden, The Netherlands. g.wezel@biology.leidenuniv.nl.ORCID http://orcid.org/0000-0003-0341-1561
Leiden University · NLWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacteria constitute a highly diverse bacterial phylum with an unrivalled metabolic versatility. They produce most of the clinically used antibiotics and a plethora of other natural products with medical or agricultural applications. Modern 'omics'-based technologies have revealed that the genomic potential of Actinobacteria greatly outmatches the known chemical space. In this Review, we argue that combining insights into actinobacterial ecology with state-of-the-art computational approaches holds great promise to unlock this unexplored reservoir of actinobacterial metabolism. This enables the identification of small molecules and other stimuli that elicit the induction of poorly expressed biosynthetic gene clusters, which should help reinvigorate screening efforts for their precious bioactive natural products.

Indexed as

Gene Expression Regulation, BacterialGenes, BacterialGenome, BacterialActinobacteriaAnti-Bacterial AgentsBiological ProductsDrug DiscoveryEcologyGene Transfer, HorizontalGenomicsHumansMetabolic Networks and PathwaysMultigene FamilyAnti-Bacterial AgentsBiological Products

Identifiers

PMID32483324
OpenAlexW3029538041

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.